Alfredo Parra-Lucares
Overview
Explore the profile of Alfredo Parra-Lucares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bravo C, Vizcarra G, Sanchez A, Cardenas F, Canales J, Ugalde H, et al.
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732308
Standard troponin has long been pivotal in diagnosing coronary syndrome, especially Non-ST-Segment Elevation Myocardial Infarction (NSTEMI). The recent introduction of high-sensitivity troponin (hs-cTnI) has elevated it to the gold standard....
2.
Toro L, Rojas V, Conejeros C, Ayala P, Parra-Lucares A, Ahumada F, et al.
Biomolecules
. 2023 Oct;
13(10).
PMID: 37892163
Acute Kidney Injury (AKI) is a frequent complication in intensive care unit (ICU) patients that increases mortality and chronic kidney disease (CKD) development. AKI is associated with elevated plasma fibroblast...
3.
Parra-Lucares A, Villa E, Romero-Hernandez E, Mendez-Valdes G, Retamal C, Vizcarra G, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629037
Atrial fibrillation (AF) is a prevalent cardiac condition predominantly affecting older adults, characterized by irregular heartbeat rhythm. The condition often leads to significant disability and increased mortality rates. Traditionally, two...
4.
Toro L, Michea L, Parra-Lucares A, Mendez-Valdes G, Villa E, Bravo I, et al.
Toxins (Basel)
. 2023 Feb;
15(2).
PMID: 36828412
Methods: We performed a prospective cohort of ESRD patients in hemodialysis who had measurements of plasma intact FGF23 in 2019. We determined COVID-19 infections, hospitalizations, and mortality between January 2020...
5.
New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back
Parra-Lucares A, Romero-Hernandez E, Villa E, Weitz-Munoz S, Vizcarra G, Reyes M, et al.
Biomedicines
. 2023 Jan;
11(1).
PMID: 36672578
Heart failure with preserved ejection fraction (HFpEF) is a growing public health problem in nearly 50% of patients with heart failure. Therefore, research on new strategies for its diagnosis and...
6.
Clavero R, Parra-Lucares A, Mendez-Valdes G, Villa E, Bravo K, Mondaca E, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146621
The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2. End-stage renal disease...
7.
Torres R, Toro L, Sanhueza M, Lorca E, Ortiz M, Pefaur J, et al.
Kidney Int Rep
. 2022 Jul;
7(10):2176-2185.
PMID: 35874643
Introduction: The COVID-19 pandemic is a global public health problem. Patients with end-stage renal disease on hemodialysis are at a higher risk of infection and mortality than the general population....
8.
Parra-Lucares A, Segura P, Rojas V, Pumarino C, Saint-Pierre G, Toro L
Life (Basel)
. 2022 Feb;
12(2).
PMID: 35207482
The COVID-19 pandemic has had a significant global impact, with more than 280,000,000 people infected and 5,400,000 deaths. The use of personal protective equipment and the anti-SARS-CoV-2 vaccination campaigns have...
9.
Parra-Lucares A, Toro L, Weitz-Munoz S, Ramos C
Viruses
. 2021 Dec;
13(12).
PMID: 34960761
The SARS-CoV-2 pandemic has mobilized many efforts worldwide to curb its impact on morbidity and mortality. Vaccination of the general population has resulted in the administration of more than 6,700,000,000...
10.
Toro L, Zamorano P, Frias A, Parra-Lucares A, Silva M, Almeida P, et al.
Rev Med Chil
. 2021 Nov;
149(5):796-802.
PMID: 34751334
COVID-19 infection causes a systemic inflammatory response, which mainly presents as a febrile syndrome with respiratory involvement. We report a 37-year-old male who consulted for myalgia, nausea and epigastric pain...